Loop Industries, Inc. LOOP Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2
adsh 0001654954-25-006337 0001654954-25-006256
cik 1504678 1504678
name LOOP INDUSTRIES, INC. LOOP INDUSTRIES, INC.
sic 2800 2800
countryba CA CA
stprba QC QC
cityba TERREBONNE TERREBONNE
zipba J6Y 1Y4 J6Y 1Y4
bas1 480 FERNAND POITRAS 480 FERNAND POITRAS
bas2
baph 450-951-8555 450-951-8555
countryma CA CA
stprma QC QC
cityma TERREBONNE TERREBONNE
zipma J6Y 1Y4 J6Y 1Y4
mas1 480 FERNAND POITRAS 480 FERNAND POITRAS
mas2
countryinc US US
stprinc NV NV
ein 272094706 272094706
former FIRST AMERICAN GROUP INC. FIRST AMERICAN GROUP INC.
changed 20101101 20101101
afs 4-NON 4-NON
wksi 0 0
fye 0228 0228
form 10-K/A 10-K
period 20250228 20250228
fy 2025 2024
fp FY FY
filed 20250530 20250529
accepted 2025-05-30 16:31:00.0 2025-05-29 17:30:00.0
prevrpt 0 0
detail 1 1
instance loop_10ka_htm.xml loop_10k_htm.xml
nciks 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001654954-25-006256 20240229 Increase Decrease In Prepaid Expense -87000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Accounts Payable And Accrued Liabilities Current 2321000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Accounts Payable And Accrued Liabilities Current 3545000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Earnings Per Share Diluted -0.3200 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Equity In Loss Of Accounted Investment 0.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Equity In Loss Of Accounted Investment 687000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006256 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20250228 Expiration Of Warrants -20385000.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Interest And Other Income 238000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Inventory Net 82000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 91355.0000 shares 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20240229 Liabilities And Stockholders Equity 20553000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Long Term Debt Current 100000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006256 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20250228 Net Income Loss -15057000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 71000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Payments To Acquire Property Plant And Equipment 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Proceeds From Distribution From Equity Investment 368000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Research And Development Expense 5133000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006256 20250228 Research And Development Expense 6864000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Restricted Stock Units Issued 778000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 797000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 797000.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006256 Equity Components= Retained Earnings;
0001654954-25-006256 20240229 Revenues 0.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Engineering Services;
0001654954-25-006256 20250228 Revenues 10889000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20230228 Shares Issued 47469224.0000 shares 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006256 20240229 Shares Issued 47528908.0000 shares 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006256 20230228 Stockholders Equity 33736000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20230228 Stockholders Equity 20385000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Stockholders Equity 14142000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Stockholders Equity 193529000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Accounts Payable And Accrued Liabilities Current 2321000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Additional Paid In Capital 171792000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Assets Current 13852000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Common Stock Value 5000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Foreign Currency Transaction Gain Loss Realized -197000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 General And Administrative Expense 2928000.0000 USD 4 us-gaap/2024 Nature Of Expense= Professional Fees;
0001654954-25-006337 20240229 General And Administrative Expense 9988000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006337 20240229 Income Taxes Paid Net 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Increase Decrease In Inventories 187000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Increase Decrease In Sales Tax And Tax Credits Receivable 322000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20250228 Interest And Other Income 238000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Inventory Write Down 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 51963.0000 shares 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20240229 Liabilities Current 2421000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Long Term Debt Current 312000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006337 20250228 Operating Expenses 25076000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Other Asset Impairment Charges 8460000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 71000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Payments To Acquire Property Plant And Equipment 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Preferred Stock Shares Issued 1.0000 shares 0 us-gaap/2024
0001654954-25-006337 20240229 Preferred Stock Shares Outstanding 1.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Prepaid Expense Current 158000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20250228 Revenues 10889000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Series B Convertible Preferred Stock Value 0.0000 USD 0 0001654954-25-006337
0001654954-25-006337 20230228 Shares Issued 1.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20230228 Stockholders Equity 33736000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20230228 Stockholders Equity 170370000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20230228 Stockholders Equity 20385000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20240229 Stockholders Equity 14142000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Restricted Stock Units Issued 778000.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006337 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Retained Earnings Accumulated Deficit -176970000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Share Based Compensation 1352000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Shares Issued 47528908.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Stockholders Equity -1070000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Stockholders Equity -176970000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Stockholders Equity 367000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20250228 Accrued Interest And Other Financing Costs 359000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Accumulated Other Comprehensive Income Loss Net Of Tax -1140000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Additional Paid In Capitalwarrants 20385000.0000 USD 0 0001654954-25-006256
0001654954-25-006256 20240229 Assets Current 7988000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Deferred Revenue Current 0.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006256 Equity Components= Retained Earnings;
0001654954-25-006256 20250228 General And Administrative Expense 9228000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Noncash Or Part Noncash Acquisition Interest Received 488000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -70000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Other Nonoperating Income Expense 870000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Payments To Acquire Interest In Joint Venture 1954000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Preferred Stock Shares Outstanding 1.0000 shares 0 us-gaap/2024
0001654954-25-006256 20240229 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Preferred Stock Value 10395.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001654954-25-006256 20240229 Proceeds From Issuance Of Convertible Preferred Stock 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Property Plant And Equipment Net 10636000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Research And Development Expense 649000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Other Research And Development Expense;
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006256 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Revenues 153000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Sales Of P E T;
0001654954-25-006256 20230228 Shares Issued 47469224.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20240229 Shares Issued 47528908.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Shares Issued 47620263.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20240229 Stockholders Equity 171792000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006256 20250228 Stockholders Equity 367000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Stock Issued During Period Shares Stock Options Exercised 10000.0000 shares 4 us-gaap/2024
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006256 20240229 Weighted Average Number Of Diluted Shares Outstanding 47522483.0000 shares 4 us-gaap/2024
0001654954-25-006337 20240229 Accounts Receivable Net Current 351000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Assets Current 7988000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6958000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -23633000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Common Stock Value 5000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006337 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Finite Lived Intangible Assets Net 1708000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 General And Administrative Expense 9228000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Increase Decrease In Deferred Revenue 102000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Interest Paid Net 257000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Investment In Joint Venture 381000.0000 USD 0 0001654954-25-006337
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Liabilities Current 3959000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Net Cash Provided By Used In Operating Activities -18046000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Net Income Loss -15057000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Noncash Or Part Noncash Acquisition Interest Received 307000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Operating Expenses 21902000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Other Nonoperating Income Expense 870000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Payables To Customers 770000.0000 USD 0 srt/2024
0001654954-25-006337 20250228 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Proceeds From Issuance Of Convertible Preferred Stock 10395000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Property Plant And Equipment Net 10636000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Property Plant And Equipment Net 8460000.0000 USD 0 us-gaap/2024 Property Plant And Equipment By Type= Machinery And Equipment;
0001654954-25-006337 20240229 Research And Development Expense 11379000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006337 20230228 Revenues 153000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Sales Of P E T;
0001654954-25-006337 20230228 Shares Issued 47469224.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20230228 Stockholders Equity -155883000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20230228 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006337 20240229 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 555000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 555000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006337 20240229 Weighted Average Number Of Diluted Shares Outstanding 47522483.0000 shares 4 us-gaap/2024
0001654954-25-006256 20240229 Accrued Interest And Other Financing Costs -159000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Additional Paid In Capital 171792000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Additional Paid In Capitalwarrants 0.0000 USD 0 0001654954-25-006256
0001654954-25-006256 20230228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 30591000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Depreciation And Amortization 535000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Earnings Per Share Diluted -0.4400 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Expiration Of Warrants 20385000.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 General And Administrative Expense 3223000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006256 20240229 Income Loss From Equity Method Investments 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Income Loss From Equity Method Investments 687000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Increase Decrease In Accounts Payable And Accrued Liabilities 1350000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Long Term Debt Noncurrent 3220000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006256 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Net Income Loss -15057000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Other Asset Impairment Charges 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20250228 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Preferred Stock Value 0.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001654954-25-006256 20250228 Proceeds From Issuance Of Convertible Preferred Stock 10395000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Property Plant And Equipment Net 1456000.0000 USD 0 us-gaap/2024 Plan Name= Buildings;
0001654954-25-006256 20240229 Property Plant And Equipment Net 226000.0000 USD 0 us-gaap/2024 Plan Name= Lands;
0001654954-25-006256 20250228 Property Plant And Equipment Net 89000.0000 USD 0 us-gaap/2024 Plan Name= Office Equipment And Furniture;
0001654954-25-006256 20240229 Research And Development Expense 11379000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006256 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006256 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Stockholders Equity -1070000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Stockholders Equity 20385000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Stock Issued During Period Shares Stock Options Exercised 7721.0000 shares 4 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Accrued Interest And Other Financing Costs 359000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Accumulated Other Comprehensive Income Loss Net Of Tax -1070000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 644000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 644000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20230228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 30591000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 12973000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Comprehensive Income Net Of Tax -15127000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Deferred Revenue Current 102000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 120000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Equity In Loss Of Accounted Investment 0.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20250228 Gain Loss On Customer Deposits 0.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 General And Administrative Expense 2680000.0000 USD 4 us-gaap/2024 Nature Of Expense= Insurance;
0001654954-25-006337 20250228 General And Administrative Expense 1871000.0000 USD 4 us-gaap/2024 Nature Of Expense= Insurance;
0001654954-25-006337 20240229 Income Loss From Equity Method Investments 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Increase Decrease In Accounts Payable And Accrued Liabilities -193000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Increase Decrease In Accounts Payable And Accrued Liabilities 1350000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Increase Decrease In Deferred Revenue 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Interest And Other Financial Expenses Income -41000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 91355.0000 shares 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20250228 Liabilities And Stockholders Equity 18578000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Long Term Debt Current 100000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006337 20240229 Long Term Debt Noncurrent 3220000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006337 20250228 Net Cash Provided By Used In Financing Activities 10318000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Payments To Acquire Interest In Joint Venture 1954000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Proceeds From Distribution From Equity Investment 0.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20250228 Proceeds From Distribution From Equity Investment 368000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Property Plant And Equipment Net 381000.0000 USD 0 us-gaap/2024 Plan Name= Building And Land Improvements;
0001654954-25-006337 20250228 Property Plant And Equipment Net 1737000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Research And Development Expense 870000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Plant And Laboratory Operating Expenses;
0001654954-25-006337 20240229 Restricted Stock Units Issued 778000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006337 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Accounts Receivable Net Current 351000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20240229 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -146000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Gain Loss On Customer Deposits 12000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 General And Administrative Expense 9988000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006256 20250228 General And Administrative Expense 1106000.0000 USD 4 us-gaap/2024 Nature Of Expense= Other;
0001654954-25-006256 20250228 General And Administrative Expense 3428000.0000 USD 4 us-gaap/2024 Nature Of Expense= Professional Fees;
0001654954-25-006256 20240229 Increase Decrease In Inventories 187000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Interest And Other Income 558000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Interest Paid Net 118000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Inventory Net 102000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Long Term Debt Current 100000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Long Term Debt Noncurrent 3220000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Net Cash Provided By Used In Investing Activities -5644000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Net Cash Provided By Used In Operating Activities -18046000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Net Cash Provided By Used In Operating Activities -2121000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Net Income Loss -21087000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20250228 Other Asset Impairment Charges 8460000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 71000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Payments To Acquire Interest In Joint Venture 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Preferred Stock Shares Issued 1.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Preferred Stock Shares Issued 1.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Property Plant And Equipment Net 125000.0000 USD 0 us-gaap/2024 Plan Name= Building And Land Improvements;
0001654954-25-006256 20250228 Property Plant And Equipment Net 1311000.0000 USD 0 us-gaap/2024 Plan Name= Buildings;
0001654954-25-006256 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006256 Equity Components= Retained Earnings;
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20230228 Revenues 153000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Sales Of P E T;
0001654954-25-006256 20240229 Revenues 153000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Revenues 368000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Engineering Services;
0001654954-25-006256 20250228 Revenues 126000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Sales Of P E T;
0001654954-25-006256 20250228 Revenues 10395000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Technology Licensing;
0001654954-25-006256 20250228 Series B Convertible Preferred Stock Value 10647000.0000 USD 0 0001654954-25-006256
0001654954-25-006256 20240229 Shares Issued 1.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20250228 Shares Issued 1.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Stock Issued During Period Shares Stock Options Exercised 7721.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 555000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Weighted Average Number Of Diluted Shares Outstanding 47587038.0000 shares 4 us-gaap/2024
0001654954-25-006337 20250228 Accumulated Other Comprehensive Income Loss Net Of Tax -1140000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Assets 20553000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Assets 18578000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001654954-25-006337 20240229 Comprehensive Income Net Of Tax -21016000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Earnings Per Share Diluted -0.3200 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -146000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Gain Loss On Customer Deposits 12000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 General And Administrative Expense 9988000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 General And Administrative Expense 1106000.0000 USD 4 us-gaap/2024 Nature Of Expense= Other;
0001654954-25-006337 20250228 General And Administrative Expense 3428000.0000 USD 4 us-gaap/2024 Nature Of Expense= Professional Fees;
0001654954-25-006337 20240229 Inventory Net 102000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Inventory Net 82000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Liabilities 18211000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Long Term Debt Noncurrent 2773000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006337 20240229 Net Income Loss -21087000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 71000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -70000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Preferred Stock Shares Authorized 25000000.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Preferred Stock Shares Authorized 25000000.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Property Plant And Equipment Net 1311000.0000 USD 0 us-gaap/2024 Plan Name= Buildings;
0001654954-25-006337 20250228 Property Plant And Equipment Net 0.0000 USD 0 us-gaap/2024 Property Plant And Equipment By Type= Machinery And Equipment;
0001654954-25-006337 20250228 Repayments Of Long Term Debt 77000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Research And Development Expense 3788000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006337 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006337 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006337 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Revenues 0.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Engineering Services;
0001654954-25-006337 20250228 Revenues 368000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Engineering Services;
0001654954-25-006337 20240229 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006337 20250228 Stockholders Equity -192027000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Stock Issued During Period Shares Stock Options Exercised 7721.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Weighted Average Number Of Diluted Shares Outstanding 47587038.0000 shares 4 us-gaap/2024
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Equity In Loss Of Accounted Investment 687000.0000 USD 4 0001654954-25-006337
0001654954-25-006256 20250228 Assets Current 13852000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 12973000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 6015000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Foreign Currency Transaction Gain Loss Realized -197000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Increase Decrease In Prepaid Expense -410000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Increase Decrease In Sales Tax And Tax Credits Receivable -731000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Interest And Other Financial Expenses Income 618000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Inventory Write Down 817000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Inventory Write Down 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Liabilities Current 2421000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Net Cash Provided By Used In Financing Activities -63000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Net Income Loss -21087000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20250228 Operating Expenses 25076000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Payables To Customers 832000.0000 USD 0 srt/2024
0001654954-25-006256 20240229 Payments To Acquire Intangible Assets 482000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Payments To Acquire Intangible Assets 450000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Preferred Stock Shares Outstanding 1.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Prepaid Expense Current 577000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Prepaid Expense Current 158000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Property Plant And Equipment Net 381000.0000 USD 0 us-gaap/2024 Plan Name= Building And Land Improvements;
0001654954-25-006256 20240229 Property Plant And Equipment Net 113000.0000 USD 0 us-gaap/2024 Plan Name= Office Equipment And Furniture;
0001654954-25-006256 20250228 Property Plant And Equipment Net 212000.0000 USD 0 us-gaap/2024 Plan Name= Lands;
0001654954-25-006256 20240229 Research And Development Expense 1142000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Machinery And Equipments;
0001654954-25-006256 20250228 Research And Development Expense 1493000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= External Engineering;
0001654954-25-006256 20250228 Research And Development Expense 64000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Machinery And Equipments;
0001654954-25-006256 20250228 Research And Development Expense 870000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Plant And Laboratory Operating Expenses;
0001654954-25-006256 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006256 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Series B Convertible Preferred Stock Value 0.0000 USD 0 0001654954-25-006256
0001654954-25-006256 20230228 Stockholders Equity -1141000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20230228 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Stockholders Equity -192027000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Accounts Payable And Accrued Liabilities Current 3545000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 6015000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Depreciation And Amortization 524000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006337 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Expiration Of Warrants -20385000.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20240229 General And Administrative Expense 3223000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006337 20250228 Income Loss From Equity Method Investments 687000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Interest Paid Net 118000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Inventory Write Down 817000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Liabilities And Stockholders Equity 20553000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Long Term Debt Noncurrent 2773000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Payments To Acquire Intangible Assets 450000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Prepaid Expense Current 577000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Property Plant And Equipment Net 89000.0000 USD 0 us-gaap/2024 Plan Name= Office Equipment And Furniture;
0001654954-25-006337 20250228 Research And Development Expense 6864000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 797000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Shares Issued 1.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Shares Issued 47528908.0000 shares 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006337 20240229 Stockholders Equity 20385000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Stockholders Equity 193529000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Stock Issued During Period Shares Stock Options Exercised 7721.0000 shares 4 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 120000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Accounts Receivable Net Current 639000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Additional Paid In Capital 193529000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 644000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 644000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20240229 Common Stock Value 5000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Common Stock Value 5000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Comprehensive Income Net Of Tax -15127000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Deferred Revenue Current 102000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Depreciation And Amortization 524000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20250228 Gain Loss On Customer Deposits 0.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 General And Administrative Expense 1871000.0000 USD 4 us-gaap/2024 Nature Of Expense= Insurance;
0001654954-25-006256 20250228 General And Administrative Expense 2823000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006256 20240229 Income Taxes Paid Net 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Increase Decrease In Accounts Payable And Accrued Liabilities -193000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Increase Decrease In Deferred Revenue 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Interest And Other Financial Expenses Income -41000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Investment In Joint Venture 381000.0000 USD 0 0001654954-25-006256
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 51963.0000 shares 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20250228 Long Term Debt Current 312000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006256 20250228 Long Term Debt Noncurrent 2773000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Net Cash Provided By Used In Investing Activities -2036000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Noncash Or Part Noncash Acquisition Interest Received 307000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Other Nonoperating Income Expense -662000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Proceeds From Distribution From Equity Investment 0.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Property Plant And Equipment Net 1737000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Repayments Of Long Term Debt 63000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Research And Development Expense 11379000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006256 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Restricted Stock Units Issued 778000.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Retained Earnings Accumulated Deficit -176970000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Revenues 0.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Technology Licensing;
0001654954-25-006256 20240229 Share Based Compensation 1422000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Share Based Compensation 1352000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20230228 Shares Issued 1.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20230228 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Stockholders Equity -176970000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Accounts Receivable Net Current 639000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Accrued Interest And Other Financing Costs -159000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20250228 Additional Paid In Capitalwarrants 0.0000 USD 0 0001654954-25-006337
0001654954-25-006337 20240229 Depreciation And Amortization 535000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Earnings Per Share Diluted -0.4400 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Expiration Of Warrants 20385000.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20240229 Finite Lived Intangible Assets Net 1548000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20250228 General And Administrative Expense 2823000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006337 20240229 Increase Decrease In Prepaid Expense -87000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Increase Decrease In Prepaid Expense -410000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Interest And Other Financial Expenses Income 618000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Net Cash Provided By Used In Financing Activities -63000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Net Cash Provided By Used In Investing Activities -2036000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Noncash Or Part Noncash Acquisition Interest Received 488000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Other Asset Impairment Charges 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Other Nonoperating Income Expense -662000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Payables To Customers 832000.0000 USD 0 srt/2024
0001654954-25-006337 20240229 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Preferred Stock Value 0.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001654954-25-006337 20250228 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Property Plant And Equipment Net 1456000.0000 USD 0 us-gaap/2024 Plan Name= Buildings;
0001654954-25-006337 20240229 Property Plant And Equipment Net 226000.0000 USD 0 us-gaap/2024 Plan Name= Lands;
0001654954-25-006337 20240229 Research And Development Expense 5133000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006337 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006337 Equity Components= Common Stock;
0001654954-25-006337 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006337 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 0.0000 USD 4 0001654954-25-006337 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Revenues 0.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Technology Licensing;
0001654954-25-006337 20240229 Share Based Compensation 1422000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20230228 Stockholders Equity -1141000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Stockholders Equity 171792000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20240229 Assets 20553000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Assets 18578000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Common Stock Shares Issued 47528908.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Finite Lived Intangible Assets Net 1708000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Foreign Currency Transaction Gain Loss Realized -63000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 General And Administrative Expense 9988000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 General And Administrative Expense 1157000.0000 USD 4 us-gaap/2024 Nature Of Expense= Other;
0001654954-25-006256 20240229 General And Administrative Expense 2928000.0000 USD 4 us-gaap/2024 Nature Of Expense= Professional Fees;
0001654954-25-006256 20250228 Increase Decrease In Inventories -14000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Increase Decrease In Sales Tax And Tax Credits Receivable 322000.0000 USD 4 0001654954-25-006256
0001654954-25-006256 20250228 Interest Paid Net 257000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Retained Earnings;
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Common Stock;
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Retained Earnings;
0001654954-25-006256 20240229 Liabilities 6411000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Liabilities 18211000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -70000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Payables To Customers 770000.0000 USD 0 srt/2024
0001654954-25-006256 20240229 Payments To Acquire Property Plant And Equipment 5162000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Preferred Stock Shares Authorized 25000000.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Preferred Stock Shares Authorized 25000000.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Property Plant And Equipment Net 0.0000 USD 0 us-gaap/2024 Property Plant And Equipment By Type= Machinery And Equipment;
0001654954-25-006256 20250228 Repayments Of Long Term Debt 77000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Research And Development Expense 433000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Other Research And Development Expense;
0001654954-25-006256 20250228 Research And Development Expense 3788000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Employee Compensation;
0001654954-25-006256 20250228 Research And Development Expense 6864000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006256 20230228 Stockholders Equity 170370000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20240229 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20250228 Stockholders Equity -1140000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006256 20250228 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Additional Paid In Capitalwarrants 20385000.0000 USD 0 0001654954-25-006337
0001654954-25-006337 20240229 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001654954-25-006337 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 General And Administrative Expense 1157000.0000 USD 4 us-gaap/2024 Nature Of Expense= Other;
0001654954-25-006337 20250228 General And Administrative Expense 9228000.0000 USD 4 us-gaap/2024 Subsegments Consolidation Items= Segment Reporting;
0001654954-25-006337 20250228 Increase Decrease In Inventories -14000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Increase Decrease In Sales Tax And Tax Credits Receivable -731000.0000 USD 4 0001654954-25-006337
0001654954-25-006337 20240229 Interest And Other Income 558000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Investment In Joint Venture 1281000.0000 USD 0 0001654954-25-006337
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20240229 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006337 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Long Term Debt Current 312000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Long Term Debt Noncurrent 3220000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Net Cash Provided By Used In Investing Activities -5644000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Net Cash Provided By Used In Operating Activities -2121000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Net Income Loss -21087000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Net Income Loss -15057000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Payments To Acquire Intangible Assets 482000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Payments To Acquire Interest In Joint Venture 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Payments To Acquire Property Plant And Equipment 5162000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Property Plant And Equipment Net 113000.0000 USD 0 us-gaap/2024 Plan Name= Office Equipment And Furniture;
0001654954-25-006337 20250228 Property Plant And Equipment Net 125000.0000 USD 0 us-gaap/2024 Plan Name= Building And Land Improvements;
0001654954-25-006337 20250228 Property Plant And Equipment Net 212000.0000 USD 0 us-gaap/2024 Plan Name= Lands;
0001654954-25-006337 20240229 Research And Development Expense 1142000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Machinery And Equipments;
0001654954-25-006337 20240229 Research And Development Expense 433000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Other Research And Development Expense;
0001654954-25-006337 20250228 Research And Development Expense 6864000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Research And Development Expense 1493000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= External Engineering;
0001654954-25-006337 20250228 Research And Development Expense 64000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Machinery And Equipments;
0001654954-25-006337 20250228 Restricted Stock Units Issued For Services 797000.0000 USD 4 0001654954-25-006337 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Retained Earnings Accumulated Deficit -192027000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Revenues 153000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Revenues 126000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Sales Of P E T;
0001654954-25-006337 20230228 Shares Issued 47469224.0000 shares 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006337 20230228 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20250228 Stockholders Equity -1140000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20240229 Accumulated Other Comprehensive Income Loss Net Of Tax -1070000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6958000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -23633000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Common Stock Shares Issued 47620263.0000 shares 0 us-gaap/2024
0001654954-25-006256 20240229 Common Stock Shares Outstanding 47528908.0000 shares 0 us-gaap/2024
0001654954-25-006256 20250228 Common Stock Shares Outstanding 47620263.0000 shares 0 us-gaap/2024
0001654954-25-006256 20240229 Comprehensive Income Net Of Tax -21016000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006256 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Finite Lived Intangible Assets Net 1548000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20240229 General And Administrative Expense 2680000.0000 USD 4 us-gaap/2024 Nature Of Expense= Insurance;
0001654954-25-006256 20250228 General And Administrative Expense 9228000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Income Taxes Paid Net 0.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Increase Decrease In Deferred Revenue 102000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Investment In Joint Venture 1281000.0000 USD 0 0001654954-25-006256
0001654954-25-006256 20250228 Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0.0000 USD 4 0001654954-25-006256 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20240229 Deferred Revenue Current 0.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Liabilities And Stockholders Equity 18578000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Liabilities Current 3959000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Long Term Debt Current 312000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20250228 Long Term Debt Noncurrent 2773000.0000 USD 0 us-gaap/2024 Debt Instrument= Investissement Quebec Financing Facility;
0001654954-25-006256 20250228 Net Cash Provided By Used In Financing Activities 10318000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20250228 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20240229 Operating Expenses 21902000.0000 USD 4 us-gaap/2024
0001654954-25-006256 20240229 Property Plant And Equipment Net 8460000.0000 USD 0 us-gaap/2024 Property Plant And Equipment By Type= Machinery And Equipment;
0001654954-25-006256 20240229 Research And Development Expense 2353000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= External Engineering;
0001654954-25-006256 20240229 Research And Development Expense 2318000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Plant And Laboratory Operating Expenses;
0001654954-25-006256 20240229 Restricted Stock Units Issued 0.0000 USD 4 0001654954-25-006256 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006256 20250228 Retained Earnings Accumulated Deficit -192027000.0000 USD 0 us-gaap/2024
0001654954-25-006256 20230228 Stockholders Equity -155883000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006256 20230228 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Interest Issued Or Issuable By Type= Stocks Common Shares;
0001654954-25-006256 20250228 Stockholders Equity 5000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 555000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006256 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20250228 Additional Paid In Capital 193529000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20240229 Common Stock Shares Issued 47528908.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Common Stock Shares Issued 47620263.0000 shares 0 us-gaap/2024
0001654954-25-006337 20240229 Common Stock Shares Outstanding 47528908.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Common Stock Shares Outstanding 47620263.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Expiration Of Warrants 0.0000 USD 4 0001654954-25-006337 Equity Components= Preferred Stock;
0001654954-25-006337 20240229 Foreign Currency Transaction Gain Loss Realized -63000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20250228 Income Taxes Paid Net 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Liabilities 6411000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Long Term Debt Current 100000.0000 USD 0 us-gaap/2024
0001654954-25-006337 20240229 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20240229 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001654954-25-006337 20250228 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -70000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-006337 20250228 Preferred Stock Shares Issued 1.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Preferred Stock Shares Outstanding 1.0000 shares 0 us-gaap/2024
0001654954-25-006337 20250228 Preferred Stock Value 10395.0000 USD 0 us-gaap/2024 Class Of Stock= Series B Preferred Stock;
0001654954-25-006337 20240229 Proceeds From Issuance Of Convertible Preferred Stock 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Repayments Of Long Term Debt 63000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Research And Development Expense 11379000.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Research And Development Expense 2353000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= External Engineering;
0001654954-25-006337 20240229 Research And Development Expense 2318000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Plant And Laboratory Operating Expenses;
0001654954-25-006337 20250228 Research And Development Expense 649000.0000 USD 4 us-gaap/2024 Research And Development Arrangement Contract To Perform For Others By Type= Other Research And Development Expense;
0001654954-25-006337 20240229 Revenues 153000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Sales Of P E T;
0001654954-25-006337 20250228 Revenues 10395000.0000 USD 4 us-gaap/2024 Deferred Revenue Arrangement Type= Technology Licensing;
0001654954-25-006337 20250228 Series B Convertible Preferred Stock Value 10647000.0000 USD 0 0001654954-25-006337
0001654954-25-006337 20250228 Shares Issued 47620263.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-006337 20250228 Shares Issued 1.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20230228 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001654954-25-006337 20250228 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;
0001654954-25-006337 20240229 Stock Issued During Period Shares Stock Options Exercised 10000.0000 shares 4 us-gaap/2024
0001654954-25-006337 20250228 Stock Issued During Period Value Issued For Services 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024
0001654954-25-006337 20240229 Stock Issued During Period Value Stock Options Exercised 0.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital Warrants;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Interest And Other Financial Expenses Income 0001654954-25-006337 1 0 monetary D C Interest and other financial expenses (income) (Note 22)
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Sales Tax And Tax Credits Receivable 0001654954-25-006337 1 0 monetary D C [Sales tax and tax credits receivable (Note 3)]
Depreciation And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Accounts Payable And Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Revenue Current us-gaap/2024 0 0 monetary I C Deferred Revenue, Current Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Gain Loss On Customer Deposits 0001654954-25-006256 1 0 monetary D C [Customer deposits]
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Prepaid Expense Current us-gaap/2024 0 0 monetary I D Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accrued Interest And Other Financing Costs 0001654954-25-006256 1 0 monetary D D Accrued interest and other financing costs (Note 22)
Restricted Stock Units Issued For Services 0001654954-25-006256 1 0 monetary D C Restricted stock units issued for services (Note 19)
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Additional Paid In Capitalwarrants 0001654954-25-006337 1 0 monetary I C Additional paid-in capital - Warrants (Note 21)
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Prepaid Expense us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
Payments To Acquire Intangible Assets us-gaap/2024 0 0 monetary D C Payments to Acquire Intangible Assets The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
Shares Issued us-gaap/2024 0 0 shares I Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
Payables To Customers srt/2024 0 0 monetary I C Broker-Dealer, Payable to Customer Amount payable to customer by broker-dealer.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Equity In Loss Of Accounted Investment 0001654954-25-006256 1 0 monetary D D [Loss on equity accounted investment (Note 11)]
Noncash Or Part Noncash Acquisition Interest Received 0001654954-25-006256 1 0 monetary D D Interest received
Accrued Interest And Other Financing Costs 0001654954-25-006337 1 0 monetary D D Accrued interest and other financing costs (Note 22)
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Repayments Of Long Term Debt us-gaap/2024 0 0 monetary D C Repayments of Long-Term Debt The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Increase Decrease In Sales Tax And Tax Credits Receivable 0001654954-25-006256 1 0 monetary D C [Sales tax and tax credits receivable (Note 3)]
Additional Paid In Capitalwarrants 0001654954-25-006256 1 0 monetary I C Additional paid-in capital - Warrants (Note 21)
Expiration Of Warrants 0001654954-25-006256 1 0 monetary D C Expiration of warrants (Note 21)
Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0001654954-25-006256 1 0 monetary D C Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), amount
Series B Convertible Preferred Stock Value 0001654954-25-006256 1 0 monetary I C Series B Convertible Preferred stock (Note 12)
Investment In Joint Venture 0001654954-25-006337 1 0 monetary I D Investments in joint ventures (Note 11) The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Inventory Write Down us-gaap/2024 0 0 monetary D D Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.
Payments To Acquire Interest In Joint Venture us-gaap/2024 0 0 monetary D C Payments to Acquire Interest in Joint Venture The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Distribution From Equity Investment 0001654954-25-006256 1 0 monetary D D Distribution from equity investment (Note 11)
Finite Lived Intangible Assets Net us-gaap/2024 0 0 monetary I D Finite-Lived Intangible Assets, Net Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Interest And Other Financial Expenses Income 0001654954-25-006256 1 0 monetary D C Interest and other financial expenses (income) (Note 22)
Restricted Stock Units Issued 0001654954-25-006337 1 0 monetary D C Restricted stock units issued (Note 19)
Interest And Other Income us-gaap/2024 0 0 monetary D C Interest and Other Income The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Proceeds From Issuance Of Convertible Preferred Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Convertible Preferred Stock The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 0001654954-25-006256 1 0 shares D Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), shares
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Equity In Loss Of Accounted Investment 0001654954-25-006337 1 0 monetary D D [Loss on equity accounted investment (Note 11)]
Noncash Or Part Noncash Acquisition Interest Received 0001654954-25-006337 1 0 monetary D D Interest received
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Restricted Stock Units Issued 0001654954-25-006256 1 0 monetary D C Restricted stock units issued (Note 19)
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Other Asset Impairment Charges us-gaap/2024 0 0 monetary D D Other Asset Impairment Charges The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Expiration Of Warrants 0001654954-25-006337 1 0 monetary D C Expiration of warrants (Note 21)
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Investment In Joint Venture 0001654954-25-006256 1 0 monetary I D Investments in joint ventures (Note 11) The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.
Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0001654954-25-006337 1 0 monetary D C Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), amount
Proceeds From Distribution From Equity Investment 0001654954-25-006337 1 0 monetary D D Distribution from equity investment (Note 11)
Restricted Stock Units Issued For Services 0001654954-25-006337 1 0 monetary D C Restricted stock units issued for services (Note 19)
Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Recognition and Exercise Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.
Foreign Currency Transaction Gain Loss Realized us-gaap/2024 0 0 monetary D C Realized Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized gain (loss) from foreign currency transaction.
Increase Decrease In Deferred Revenue us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.
Long Term Debt Current us-gaap/2024 0 0 monetary I C Long-Term Debt, Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
Long Term Debt Noncurrent us-gaap/2024 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Gain Loss On Customer Deposits 0001654954-25-006337 1 0 monetary D C [Customer deposits]
Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 0001654954-25-006337 1 0 shares D Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), shares
Series B Convertible Preferred Stock Value 0001654954-25-006337 1 0 monetary I C Series B Convertible Preferred stock (Note 12)

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001654954-25-006256 2 2 BS 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents 0
0001654954-25-006256 2 3 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable (Note 3) 0
0001654954-25-006256 2 4 BS 0 H Inventory Net us-gaap/2024 Inventories (Note 4) 0
0001654954-25-006256 2 5 BS 0 H Prepaid Expense Current us-gaap/2024 Prepaid expenses (Note 5) 0
0001654954-25-006256 2 6 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001654954-25-006256 2 7 BS 0 H Investment In Joint Venture 0001654954-25-006256 Investments in joint ventures (Note 11) 0
0001654954-25-006256 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment, net (Note 6) 0
0001654954-25-006256 2 9 BS 0 H Finite Lived Intangible Assets Net us-gaap/2024 Intangible assets, net (Note 7) 0
0001654954-25-006256 2 10 BS 0 H Assets us-gaap/2024 Total assets 0
0001654954-25-006256 2 12 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued liabilities (Note 9) 0
0001654954-25-006256 2 13 BS 0 H Deferred Revenue Current us-gaap/2024 Unearned revenue (Note 16) 0
0001654954-25-006256 2 14 BS 0 H Long Term Debt Current us-gaap/2024 Current portion of long-term debt (Note 13) 0
0001654954-25-006256 2 15 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001654954-25-006256 2 16 BS 0 H Payables To Customers srt/2024 Due to customer (Note 10) 0
0001654954-25-006256 2 17 BS 0 H Series B Convertible Preferred Stock Value 0001654954-25-006256 Series B Convertible Preferred stock (Note 12) 0
0001654954-25-006256 2 18 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long-term debt (Note 13) 0
0001654954-25-006256 2 19 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001654954-25-006256 2 21 BS 0 H Preferred Stock Value us-gaap/2024 Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding (Note 15) 0
0001654954-25-006256 2 22 BS 0 H Common Stock Value us-gaap/2024 Common stock par value $0.0001; 250,000,000 shares authorized; 47,620,263 shares issued and outstanding (2024 - 47,528,908) (Note 15) 0
0001654954-25-006256 2 23 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001654954-25-006256 2 24 BS 0 H Additional Paid In Capitalwarrants 0001654954-25-006256 Additional paid-in capital - Warrants (Note 21) 0
0001654954-25-006256 2 25 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001654954-25-006256 2 26 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0001654954-25-006256 2 27 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity 0
0001654954-25-006256 2 28 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0001654954-25-006256 3 2 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Series A preferred stock, par value 0
0001654954-25-006256 3 3 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Series A preferred stock, share authorized 0
0001654954-25-006256 3 4 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Series A preferred stock, share issued 0
0001654954-25-006256 3 5 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Series A preferred stock, share outstanding 0
0001654954-25-006256 3 6 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001654954-25-006256 3 7 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001654954-25-006256 3 8 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001654954-25-006256 3 9 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001654954-25-006256 4 1 IS 0 H Revenues us-gaap/2024 Revenues (Note 16) 0
0001654954-25-006256 4 3 IS 0 H Research And Development Expense us-gaap/2024 Research and development (Note 17) 0
0001654954-25-006256 4 4 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative (Note 18) 0
0001654954-25-006256 4 5 IS 0 H Other Asset Impairment Charges us-gaap/2024 Impairment of equipment (Note 6) 0
0001654954-25-006256 4 6 IS 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization (Notes 6 and 7) 0
0001654954-25-006256 4 7 IS 0 H Operating Expenses us-gaap/2024 Total expenses 0
0001654954-25-006256 4 9 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 Loss on equity accounted investment (Note 11) 0
0001654954-25-006256 4 10 IS 0 H Interest And Other Financial Expenses Income 0001654954-25-006256 Interest and other financial expenses (income) (Note 22) 0
0001654954-25-006256 4 11 IS 0 H Interest And Other Income us-gaap/2024 Interest income 0
0001654954-25-006256 4 12 IS 0 H Foreign Currency Transaction Gain Loss Realized us-gaap/2024 Foreign exchange gain 0
0001654954-25-006256 4 13 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Total other loss (income) 0
0001654954-25-006256 4 14 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001654954-25-006256 4 15 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0001654954-25-006256 4 16 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive loss 0
0001654954-25-006256 4 18 IS 0 H Earnings Per Share Diluted us-gaap/2024 Basic and diluted 0
0001654954-25-006256 4 19 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Basic and diluted 0
0001654954-25-006256 5 11 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-006256 5 12 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-006256 5 13 EQ 0 H Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 0001654954-25-006256 Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), shares 0
0001654954-25-006256 5 14 EQ 0 H Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0001654954-25-006256 Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), amount 0
0001654954-25-006256 6 18 CF 0 H Payments To Acquire Interest In Joint Venture us-gaap/2024 Investment in joint venture (Note 11) 1
0001654954-25-006256 6 19 CF 0 H Proceeds From Distribution From Equity Investment 0001654954-25-006256 Distribution from equity investment (Note 11) 0
0001654954-25-006256 6 20 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Additions to property, plant and equipment (Note 6) 1
0001654954-25-006256 6 21 CF 0 H Payments To Acquire Intangible Assets us-gaap/2024 Additions to intangible assets (Note 7) 1
0001654954-25-006256 6 22 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash (used in) investing activities 0
0001654954-25-006256 6 24 CF 0 H Proceeds From Issuance Of Convertible Preferred Stock us-gaap/2024 Proceeds from issuance of series B Convertible Preferred stock (Note 12) 0
0001654954-25-006256 6 25 CF 0 H Repayments Of Long Term Debt us-gaap/2024 Repayment of long-term debt (Note 13) 1
0001654954-25-006256 6 26 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by (used in) financing activities 0
0001654954-25-006256 6 27 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes 0
0001654954-25-006256 6 28 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net change in cash and cash equivalents 0
0001654954-25-006256 6 29 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents, beginning of year 0
0001654954-25-006256 6 30 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents, end of year 0
0001654954-25-006256 6 31 CF 0 H Income Taxes Paid Net us-gaap/2024 Income tax paid 0
0001654954-25-006256 6 32 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001654954-25-006256 6 33 CF 0 H Noncash Or Part Noncash Acquisition Interest Received 0001654954-25-006256 Interest received 0
0001654954-25-006337 2 2 BS 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents 0
0001654954-25-006337 2 3 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable (Note 3) 0
0001654954-25-006337 2 4 BS 0 H Inventory Net us-gaap/2024 Inventories (Note 4) 0
0001654954-25-006337 2 5 BS 0 H Prepaid Expense Current us-gaap/2024 Prepaid expenses (Note 5) 0
0001654954-25-006337 2 6 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001654954-25-006337 2 7 BS 0 H Investment In Joint Venture 0001654954-25-006337 Investments in joint ventures (Note 11) 0
0001654954-25-006337 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment, net (Note 6) 0
0001654954-25-006337 2 9 BS 0 H Finite Lived Intangible Assets Net us-gaap/2024 Intangible assets, net (Note 7) 0
0001654954-25-006337 2 10 BS 0 H Assets us-gaap/2024 Total assets 0
0001654954-25-006337 2 12 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued liabilities (Note 9) 0
0001654954-25-006337 2 13 BS 0 H Deferred Revenue Current us-gaap/2024 Unearned revenue (Note 16) 0
0001654954-25-006337 2 14 BS 0 H Long Term Debt Current us-gaap/2024 Current portion of long-term debt (Note 13) 0
0001654954-25-006337 2 15 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001654954-25-006337 2 16 BS 0 H Payables To Customers srt/2024 Due to customer (Note 10) 0
0001654954-25-006337 2 17 BS 0 H Series B Convertible Preferred Stock Value 0001654954-25-006337 Series B Convertible Preferred stock (Note 12) 0
0001654954-25-006337 2 18 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long-term debt (Note 13) 0
0001654954-25-006337 2 19 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001654954-25-006337 2 21 BS 0 H Preferred Stock Value us-gaap/2024 Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding (Note 15) 0
0001654954-25-006337 2 22 BS 0 H Common Stock Value us-gaap/2024 Common stock par value $0.0001; 250,000,000 shares authorized; 47,620,263 shares issued and outstanding (2024 - 47,528,908) (Note 15) 0
0001654954-25-006337 2 23 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001654954-25-006337 2 24 BS 0 H Additional Paid In Capitalwarrants 0001654954-25-006337 Additional paid-in capital - Warrants (Note 21) 0
0001654954-25-006337 2 25 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001654954-25-006337 2 26 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0001654954-25-006337 2 27 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity 0
0001654954-25-006337 2 28 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0001654954-25-006337 3 2 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Series A preferred stock, par value 0
0001654954-25-006337 3 3 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Series A preferred stock, share authorized 0
0001654954-25-006337 3 4 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Series A preferred stock, share issued 0
0001654954-25-006337 3 5 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Series A preferred stock, share outstanding 0
0001654954-25-006337 3 6 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001654954-25-006337 3 7 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001654954-25-006337 3 8 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001654954-25-006337 3 9 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001654954-25-006337 4 1 IS 0 H Revenues us-gaap/2024 Revenues (Note 16) 0
0001654954-25-006337 4 3 IS 0 H Research And Development Expense us-gaap/2024 Research and development (Note 17) 0
0001654954-25-006337 4 4 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative (Note 18) 0
0001654954-25-006337 4 5 IS 0 H Other Asset Impairment Charges us-gaap/2024 Impairment of equipment (Note 6) 0
0001654954-25-006337 4 6 IS 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization (Notes 6 and 7) 0
0001654954-25-006337 4 7 IS 0 H Operating Expenses us-gaap/2024 Total expenses 0
0001654954-25-006337 4 9 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 Loss on equity accounted investment (Note 11) 0
0001654954-25-006337 4 10 IS 0 H Interest And Other Financial Expenses Income 0001654954-25-006337 Interest and other financial expenses (income) (Note 22) 0
0001654954-25-006337 4 11 IS 0 H Interest And Other Income us-gaap/2024 Interest income 0
0001654954-25-006337 4 12 IS 0 H Foreign Currency Transaction Gain Loss Realized us-gaap/2024 Foreign exchange gain 0
0001654954-25-006337 4 13 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Total other loss (income) 0
0001654954-25-006337 4 14 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001654954-25-006337 4 15 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0001654954-25-006337 4 16 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive loss 0
0001654954-25-006337 4 18 IS 0 H Earnings Per Share Diluted us-gaap/2024 Basic and diluted 0
0001654954-25-006337 4 19 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Basic and diluted 0
0001654954-25-006337 5 11 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-006337 5 12 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-006337 5 13 EQ 0 H Issuance Of Shares Upon The Settlement Of Restricted Stock Units Shares 0001654954-25-006337 Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), shares 0
0001654954-25-006337 5 14 EQ 0 H Issuance Of Shares Upon The Settlement Of Restricted Stock Units Amount 0001654954-25-006337 Issuance of shares upon the settlement of restricted stock units (Notes 15 and 19), amount 0
0001654954-25-006337 5 15 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Issuance of shares upon the exercise of stock options (Notes 15 and 19), shares 0
0001654954-25-006337 5 16 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Issuance of shares upon the exercise of stock options (Notes 15 and 19), amount 0
0001654954-25-006337 5 17 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options us-gaap/2024 Stock options issued (Note 19) 0
0001654954-25-006337 5 18 EQ 0 H Restricted Stock Units Issued 0001654954-25-006337 Restricted stock units issued (Note 19) 0
0001654954-25-006337 5 19 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation 0
0001654954-25-006337 5 20 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001654954-25-006337 5 21 EQ 0 H Expiration Of Warrants 0001654954-25-006337 Expiration of warrants (Note 21) 0
0001654954-25-006337 5 22 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Stock options issued for services (Note 19) 0
0001654954-25-006337 5 23 EQ 0 H Restricted Stock Units Issued For Services 0001654954-25-006337 Restricted stock units issued for services (Note 19) 0
0001654954-25-006337 5 24 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-006337 5 25 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-006337 6 1 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001654954-25-006337 6 3 CF 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization (Notes 6 and 7) 0
0001654954-25-006337 6 4 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation (Note 19) 0
0001654954-25-006337 6 5 CF 0 H Inventory Write Down us-gaap/2024 Write-down of inventory (Note 4) 0
0001654954-25-006337 6 6 CF 0 H Accrued Interest And Other Financing Costs 0001654954-25-006337 Accrued interest and other financing costs (Note 22) 0
0001654954-25-006337 6 7 CF 0 H Other Asset Impairment Charges us-gaap/2024 Impairment of equipment (Note 6) 0
0001654954-25-006337 6 8 CF 0 H Equity In Loss Of Accounted Investment 0001654954-25-006337 Loss on equity accounted investment (Note 11) 0
0001654954-25-006337 6 9 CF 0 H Gain Loss On Customer Deposits 0001654954-25-006337 Customer deposits 1
0001654954-25-006337 6 11 CF 0 H Increase Decrease In Sales Tax And Tax Credits Receivable 0001654954-25-006337 Sales tax and tax credits receivable (Note 3) 1
0001654954-25-006337 6 12 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories (Note 4) 1
0001654954-25-006337 6 13 CF 0 H Increase Decrease In Prepaid Expense us-gaap/2024 Prepaid expenses (Note 5) 1
0001654954-25-006337 6 14 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued liabilities (Note 9) 0
0001654954-25-006337 6 15 CF 0 H Increase Decrease In Deferred Revenue us-gaap/2024 Unearned revenue (Note 16) 0
0001654954-25-006337 6 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash (used in) operating activities 0
0001654954-25-006337 6 18 CF 0 H Payments To Acquire Interest In Joint Venture us-gaap/2024 Investment in joint venture (Note 11) 1
0001654954-25-006337 6 19 CF 0 H Proceeds From Distribution From Equity Investment 0001654954-25-006337 Distribution from equity investment (Note 11) 0
0001654954-25-006337 6 20 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Additions to property, plant and equipment (Note 6) 1
0001654954-25-006337 6 21 CF 0 H Payments To Acquire Intangible Assets us-gaap/2024 Additions to intangible assets (Note 7) 1
0001654954-25-006337 6 22 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash (used in) investing activities 0
0001654954-25-006337 6 24 CF 0 H Proceeds From Issuance Of Convertible Preferred Stock us-gaap/2024 Proceeds from issuance of series B Convertible Preferred stock (Note 12) 0
0001654954-25-006337 6 25 CF 0 H Repayments Of Long Term Debt us-gaap/2024 Repayment of long-term debt (Note 13) 1
0001654954-25-006337 6 26 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by (used in) financing activities 0
0001654954-25-006337 6 27 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes 0
0001654954-25-006337 6 28 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net change in cash and cash equivalents 0
0001654954-25-006337 6 29 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents, beginning of year 0
0001654954-25-006337 6 30 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents, end of year 0
0001654954-25-006337 6 31 CF 0 H Income Taxes Paid Net us-gaap/2024 Income tax paid 0
0001654954-25-006337 6 32 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001654954-25-006337 6 33 CF 0 H Noncash Or Part Noncash Acquisition Interest Received 0001654954-25-006337 Interest received 0
0001654954-25-006256 5 15 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Issuance of shares upon the exercise of stock options (Notes 15 and 19), shares 0
0001654954-25-006256 5 16 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Issuance of shares upon the exercise of stock options (Notes 15 and 19), amount 0
0001654954-25-006256 5 17 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options us-gaap/2024 Stock options issued (Note 19) 0
0001654954-25-006256 5 18 EQ 0 H Restricted Stock Units Issued 0001654954-25-006256 Restricted stock units issued (Note 19) 0
0001654954-25-006256 5 19 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation 0
0001654954-25-006256 5 20 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001654954-25-006256 5 21 EQ 0 H Expiration Of Warrants 0001654954-25-006256 Expiration of warrants (Note 21) 0
0001654954-25-006256 5 22 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Stock options issued for services (Note 19) 0
0001654954-25-006256 5 23 EQ 0 H Restricted Stock Units Issued For Services 0001654954-25-006256 Restricted stock units issued for services (Note 19) 0
0001654954-25-006256 5 24 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-006256 5 25 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-006256 6 1 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001654954-25-006256 6 3 CF 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization (Notes 6 and 7) 0
0001654954-25-006256 6 4 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation (Note 19) 0
0001654954-25-006256 6 5 CF 0 H Inventory Write Down us-gaap/2024 Write-down of inventory (Note 4) 0
0001654954-25-006256 6 6 CF 0 H Accrued Interest And Other Financing Costs 0001654954-25-006256 Accrued interest and other financing costs (Note 22) 0
0001654954-25-006256 6 7 CF 0 H Other Asset Impairment Charges us-gaap/2024 Impairment of equipment (Note 6) 0
0001654954-25-006256 6 8 CF 0 H Equity In Loss Of Accounted Investment 0001654954-25-006256 Loss on equity accounted investment (Note 11) 0
0001654954-25-006256 6 9 CF 0 H Gain Loss On Customer Deposits 0001654954-25-006256 Customer deposits 1
0001654954-25-006256 6 11 CF 0 H Increase Decrease In Sales Tax And Tax Credits Receivable 0001654954-25-006256 Sales tax and tax credits receivable (Note 3) 1
0001654954-25-006256 6 12 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories (Note 4) 1
0001654954-25-006256 6 13 CF 0 H Increase Decrease In Prepaid Expense us-gaap/2024 Prepaid expenses (Note 5) 1
0001654954-25-006256 6 14 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued liabilities (Note 9) 0
0001654954-25-006256 6 15 CF 0 H Increase Decrease In Deferred Revenue us-gaap/2024 Unearned revenue (Note 16) 0
0001654954-25-006256 6 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash (used in) operating activities 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.